Please login to the form below

Not currently logged in
Email:
Password:

leprosy

This page shows the latest leprosy news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Egatan gains US approval for neglected tropical disease

Novartis’ Egatan gains US approval for neglected tropical disease

Novartis has a long-standing commitment to addressing global health challenges and supporting disease elimination efforts, in diseases such as leprosy, malaria and fascioliasis,” said Vas Narasimhan, CEO of Novartis (below).

Latest news

  • Novartis sets sights on eliminating leprosy Novartis sets sights on eliminating leprosy

    The new strategy focuses on interrupting leprosy transmission through early diagnosis and treatment, contact tracing of former patients, diagnostic tools and strict surveillance and response, according to Novartis. ... of the Novartis Foundation, which

  • Novartis to expand SMS for Life approach across Africa Novartis to expand SMS for Life approach across Africa

    SMS for Life now reaches all 5, 000 public health facilities across Tanzania, where the programme has also added the tracking of medicines for tuberculosis and leprosy.

  • Medicine donations helping in battle against tropical diseases Medicine donations helping in battle against tropical diseases

    By 2020, the WHO anticipates leprosy, blinding trachoma, sleeping sickness (human African trypanosomiasis) and lymphatic filariasis to be eliminated worldwide, while rabies, chages disease, visceral leishmaniasis and schistosomiasis and

  • Navigating the minefield

    These include Mectizan for 'river blindness', Mycobutin for leprosy, Vibramycin for malaria and Capastat for tuberculosis.

  • Novartis extends WHO leprosy collaboration

    Novartis has announced it is to extend its collaboration with the World Health Organization to help end leprosy. ... Cases of leprosy have decreased 95 per cent over the past 20 years.

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics